loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 208684 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    PTC Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DEFLAZACORT (4)

    filter

    01 PTC THERAP (4)

    filter

    01 TABLET;ORAL (4)

    filter

    01 18MG (1)

    02 30MG (1)

    03 36MG (1)

    04 6MG (1)

    filter

    01 USA (4)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Deflazacort

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET;ORAL
      36MG
      EMFLAZA
      USA
      208684
      2017-02-09
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Deflazacort

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET;ORAL
        18MG
        EMFLAZA
        USA
        208684
        2017-02-09
        RX
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Deflazacort

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET;ORAL
          30MG
          EMFLAZA
          USA
          208684
          2017-02-09
          RX
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content
          Contact Supplier
            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
            Post an Enquiry Post an Enquiry
            Flag U.S.A
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Deflazacort

            PDF Supplier PDF
            URL Supplier Web Content
            TABLET;ORAL
            6MG
            EMFLAZA
            USA
            208684
            2017-02-09
            RX
            ASK
            US
            PHARMACOMPASS
            Upload
            your Marketing & Sales content

            Looking for CTD TGA MCC DOSSIER APPLICATION 208684

            Looking for CTD TGA MCC DOSSIER APPLICATION 208684 4

            19

            PTC Therapeutics, based in U.S.A, is a pharmaceutical company.

            One of their notable products is DEFLAZACORT, with a corresponding application number 208684 and regulatory information .

            proudly manufactured in the

            approval since 2017-02-09

            PTC Therapeutics's EMFLAZA TABLET;ORAL, medication with 36MG of DEFLAZACORT.

            18

            PTC Therapeutics, based in U.S.A, is a pharmaceutical company.

            One of their notable products is DEFLAZACORT, with a corresponding application number 208684 and regulatory information .

            proudly manufactured in the

            approval since 2017-02-09

            PTC Therapeutics's EMFLAZA TABLET;ORAL, medication with 18MG of DEFLAZACORT.

            17

            PTC Therapeutics, based in U.S.A, is a pharmaceutical company.

            One of their notable products is DEFLAZACORT, with a corresponding application number 208684 and regulatory information .

            proudly manufactured in the

            approval since 2017-02-09

            PTC Therapeutics's EMFLAZA TABLET;ORAL, medication with 30MG of DEFLAZACORT.

            16

            PTC Therapeutics, based in U.S.A, is a pharmaceutical company.

            One of their notable products is DEFLAZACORT, with a corresponding application number 208684 and regulatory information .

            proudly manufactured in the

            approval since 2017-02-09

            PTC Therapeutics's EMFLAZA TABLET;ORAL, medication with 6MG of DEFLAZACORT.

            Post Enquiry
            POST ENQUIRY